A Study to Evaluate the Efficacy and Safety of AD-224

Conditions: Hypertension,Essential Interventions: Drug: AD-224A; Drug: AD-224B; Drug: AD-224C Sponsors: Addpharma Inc. Not yet recruiting

Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials